Regular visits to the doctor, keeping a strict fitness routine and dieting are perceived to be the most important elements in managing and preventing diabetes, according to a recent online survey of more than 500 AccentHealth viewers with diabetes or a family history of diabetes. As many as 94% of respondents visited their doctor regularly, and the same number of respondents exercised regularly. To see more Patient Views, click here.
Among diabetes sufferers and those with a diabetic in their household, the critical role of the physician in condition management is most visible, according to a recent online survey of more than 500 AccentHealth viewers. Eight-in-10 indicate their doctor is very or somewhat involved in their own or their household member's diabetes management; half report their doctor is their primary source for condition info — 43% more than those using the second-most common source, health-related web sites.
Making regular doctor appointments is the activity done most often by respondents (78%) to live a healthy life, at least 10 percentage points higher than diet and exercise, according to a recent online survey of more than 500 AccentHealth viewers with diabetes or a family history of diabetes. As many as 70% limit alcohol consumption, and 68% monitor their diet.
Data recently presented at t AADE15 suggests that people with type 2 diabetes can lower their blood sugar and benefit from following a structured, personalized self-monitoring blood glucose schedule even if they don’t require insulin.
The focus on education at McKesson’s ideaShare 2015 didn’t stop when the exhibit hall opened Thursday evening. Friday and Saturday in San Diego saw a robust lineup of Continuing Education and Lunch & Learn sessions that aimed to keep independent pharmacy owners and pharmacists apprised of the latest developments in patient care and the current state of the business.
The $1.1 billion deal is expected to close in the first quarter of 2016 and will include Bayer’s Contour line of blood glucose monitors and test strips, as well as lancing devices like Microlet and Elite.
The American Pharmacists Association Foundation’s diabetes management solution, the Patient Self-Management Credential for Diabetes, was highlighted at the Healthcare Leadership Council’s wellness briefing.
Miraculins in January announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario beginning in February.
Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.